当前位置：
X-MOL 学术
›
Bioconjugate Chem.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to “Complement Inhibitors Block Complement C3 Opsonization and Improve Targeting Selectivity of Nanoparticles in Blood”
Bioconjugate Chemistry ( IF 4.7 ) Pub Date : 2021-09-03 , DOI: 10.1021/acs.bioconjchem.1c00396 Hanmant Gaikwad , Yue Li , Geoffrey Gifford , Ernest Groman , Nirmal K Banda , Laura Saba , Robert Scheinman , Guankui Wang , Dmitri Simberg
Bioconjugate Chemistry ( IF 4.7 ) Pub Date : 2021-09-03 , DOI: 10.1021/acs.bioconjchem.1c00396 Hanmant Gaikwad , Yue Li , Geoffrey Gifford , Ernest Groman , Nirmal K Banda , Laura Saba , Robert Scheinman , Guankui Wang , Dmitri Simberg
The following correction is requested: sCR1–3 should be called sCR2–4 throughout the manuscript. This article has not yet been cited by other publications.
中文翻译：
更正“补体抑制剂阻断补体 C3 调理作用并提高血液中纳米颗粒的靶向选择性”
要求进行以下更正：在整个手稿中，sCR1-3 应称为 sCR2-4。这篇文章还没有被其他出版物引用。
更新日期：2021-09-15
中文翻译：
更正“补体抑制剂阻断补体 C3 调理作用并提高血液中纳米颗粒的靶向选择性”
要求进行以下更正：在整个手稿中，sCR1-3 应称为 sCR2-4。这篇文章还没有被其他出版物引用。
京公网安备 11010802027423号